

ABOUT THE
FOUNDER
Rae Knight
B.SC., DVM, MRCVS.
Dr. Rae Knight is a licensed veterinarian whose 40‑year career bridges hands‑on clinical practice and influential leadership in the global animal health industry. After owning and managing mixed‑animal clinics, she transitioned into pharmacovigilance, building a 20‑year career with Novartis, Eli Lilly, and Elanco. Her roles—from call‑center veterinarian to Canadian PV Manager, EU QPPV, and Global PV Consultant—reflect a deep commitment to product safety and regulatory integrity. Rae was instrumental in implementing EU Regulation 2019/6, creating systems that strengthened compliance and operational clarity. A Lean Six Sigma Black Belt, she is known for her analytical rigor, process excellence, and collaborative approach. Today, as founder of Pippins Veterinary Pharmacovigilance Consulting, she supports companies through practical PV guidance, regulatory training, and compliance‑focused solutions.


Services
Pharmacovigilance Consulting
As Pharmacovigilance (PV) Consultants with global expertise and comprehensive understanding of regulatory environments and PV-related databases, we specialize in:
-
Regulatory intelligence
-
PV audits
-
PV management
-
Benefit: risk-based product safety strategies
-
Study protocol management
-
Compliant adverse event (AE) recording and reporting
-
Process efficiency
-
Regulatory and audit-ready training
-
SOP and Guidance document preparation
With Black Belt certification in Lean Six Sigma, we excel in leading projects and empowering teams to drive continuous process improvement, innovation, and efficiency.
We provide guidance on general PV management, leveraging adverse event (AE) data for enhanced process efficiency, improved product safety insights, to help ensure compliant AE data recording, and reporting, and audit-readiness.

Collaboration and Compliance
Collaboration with Clients
Compliance with Regulatory Standards
We prioritize compliance with government regulations on adverse event reporting and safety signal management, and collaborate with our industry partners to guide them towards positive benefit: risk drug profiles, and safety with the use of their animal medicines.
